Profound Medical (PROF) Gross Margin Growth (1y) (2020 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -67.00 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | -54.00 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -265.00 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 62.00 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -65.00 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 9.00 |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 610.00 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -359.00 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 58.00 |
| 10 | Profound Medical | 244.28 Mn | 193.99 Mn | 3.83 Mn | 110.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 110.00 |
| Dec 31, 2025 | -416.00 |
| Sep 30, 2025 | 399.00 |
| Jun 30, 2025 | 42.00 |
| Mar 31, 2025 | 1,052.00 |
| Dec 31, 2024 | -6,856.00 |
| Sep 30, 2024 | 900.00 |
| Jun 30, 2024 | 722.00 |
| Mar 31, 2024 | -503.00 |
| Dec 31, 2023 | 15,584.00 |
| Sep 30, 2023 | 778.00 |
| Jun 30, 2023 | 1,932.00 |
| Mar 31, 2023 | 3,325.00 |
| Dec 31, 2022 | -6,614.00 |
| Sep 30, 2022 | 1,466.00 |
| Jun 30, 2022 | -7.00 |
| Mar 31, 2022 | -348.00 |
| Dec 31, 2021 | 1,011.00 |
| Sep 30, 2021 | -2,691.00 |
| Jun 30, 2021 | 574.00 |
| Mar 31, 2021 | -266.00 |
| Dec 31, 2020 | 11,617.00 |
| Sep 30, 2020 | 2,372.00 |
| Jun 30, 2020 | -1,694.00 |
| Mar 31, 2020 | -2,576.00 |